July 29, 2025
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The purpose of this Notice is to inform potential applicants that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is participating in PAR-25-442, "Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed), effective with publication of this Notice.
The following italicized text has been added to PAR-25-442 to reflect NICHD's participation in the NOFO:
Part 1. Overview Information
Components of Participating Organizations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Part 1. Overview Information
Assistance Listing Number(s): 93.865
Part 2. Full Text of Announcement
Section I. Notice of Funding Opportunity Description
Research Objectives and Scope
Topics of Low Programmatic Priority
Diseases, conditions, and targets that address the mission and priorities of other ICOs will not be prioritized for funding by NICHD. Prospective applicants are strongly encouraged to discuss potential applications with the Scientific Contact at NICHD. Additional information on extramural research areas at the NICHD can be found here - https://www.nichd.nih.gov/about/org/der/branches.
Section VII. Agency Contacts
Scientific/Research Contact(s)
Aaron C. Pawlyk, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-451-7299
Email: [email protected]
Financial/Grants Management Contact(s)
Melinda Bixby
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-3204
Email: [email protected]
All the other aspects of the NOFO remain the same.
Please direct all inquiries to:
Aaron C. Pawlyk, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-451-7299
Email: [email protected]